The U.S. healthcare system has been broken for some time.
In fact, according to 70% of U.S. adults, as noted by Time, the health care system is failing to meet their needs in at least one way.
High costs, ridiculous wait times, poor communication, a severe lack of personalized care, and the impersonal nature of the system is a concern for many, with millions of patients feeling more like a number than a real person.
Not helping, multi-billion-dollar pharmaceutical companies have been exerting considerable influence over the U.S. FDA, raising concerns the agency is putting pharmaceutical company profits and needs well ahead of patients.
But that’s changing.
Helping, Health and Human Services Secretary Robert F. Kennedy Jr. is not only transforming U.S. health policy, he’s also restructuring the focus of some regulators and researchers, and reshaping the mission of his department to focus more on alternative medicine.
Plus, more Americans are also far more proactive about their health, looking for ways to maintain their well-being, leading to their willingness to consider supplements.
We’re also seeing substantial demand for self-care digital platforms, fueled by health awareness, convenience, personalization, and cost-savings issues. Also, with more Americans now far more proactive about their health, they’re looking for ways to feel and look good, with digital platforms offering quick, convenient information.
In short, a major health revolution is now underway in North America.
With it, the digital health market is absolutely exploding, with experts projecting that the current $288 billion industry will more than triple in size by 2030.
To potentially profit…
We can always look at digital health stocks, such as Hims & Hers Health (SYM: HIMS), a $14.7 billion digital health company that uses telehealth platforms to connect consumers with licensed healthcare professionals.
We can also look at ETFs such as the Global X HealthTech ETF (SYM: HEAL).
Last trading at $10.30, the HEAL ETF invests in companies that are transforming healthcare with technology. That includes AI-enabled drug discovery, smart medical devices, tech-enabled consumer healthcare and healthcare analytics.
In fact, some of its 40 holdings include Hims & Hers Health, Resmed Inc., Transmedics Group, GE Healthcare Technology, Tempus AI, and Oscar Health, to name just a few.
Read in Behind the Markets: Why Is President Trump Fast-Tracking These Companies?
